Page last updated: 2024-08-22

cobaltous chloride and Bladder Cancer

cobaltous chloride has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koga, F; Neckers, LM; Tsutsumi, S1

Other Studies

1 other study(ies) available for cobaltous chloride and Bladder Cancer

ArticleYear
Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
    Cell cycle (Georgetown, Tex.), 2007, Jun-01, Volume: 6, Issue:11

    Topics: Antibiotics, Antineoplastic; Benzoquinones; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Extracellular Matrix Proteins; Feedback, Physiological; Female; Fibronectins; Focal Adhesions; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Integrin beta3; Lactams, Macrocyclic; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Proto-Oncogene Proteins c-met; Stress Fibers; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A

2007